| Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel H Döhner, E Estey, D Grimwade, S Amadori, FR Appelbaum, T Büchner, ... Blood, The Journal of the American Society of Hematology 129 (4), 424-447, 2017 | 5826 | 2017 |
| Genomic aberrations and survival in chronic lymphocytic leukemia H Döhner, S Stilgenbauer, A Benner, E Leupolt, A Kröber, L Bullinger, ... New England Journal of Medicine 343 (26), 1910-1916, 2000 | 4353 | 2000 |
| Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet H Döhner, EH Estey, S Amadori, FR Appelbaum, T Büchner, AK Burnett, ... Blood, The Journal of the American Society of Hematology 115 (3), 453-474, 2010 | 4317 | 2010 |
| Genomic classification and prognosis in acute myeloid leukemia E Papaemmanuil, M Gerstung, L Bullinger, VI Gaidzik, P Paschka, ... New England Journal of Medicine 374 (23), 2209-2221, 2016 | 3993 | 2016 |
| Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National … M Hallek, BD Cheson, D Catovsky, F Caligaris-Cappio, G Dighiero, ... Blood, The Journal of the American Society of Hematology 111 (12), 5446-5456, 2008 | 3938 | 2008 |
| Acute myeloid leukemia H Döhner, DJ Weisdorf, CD Bloomfield New England Journal of Medicine 373 (12), 1136-1152, 2015 | 3545 | 2015 |
| Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic … BD Cheson, JM Bennett, KJ Kopecky, T Büchner, CL Willman, EH Estey, ... Journal of clinical oncology 21 (24), 4642-4649, 2003 | 3036 | 2003 |
| Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial M Hallek, K Fischer, G Fingerle-Rowson, AM Fink, R Busch, J Mayer, ... The Lancet 376 (9747), 1164-1174, 2010 | 2397 | 2010 |
| Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation RM Stone, SJ Mandrekar, BL Sanford, K Laumann, S Geyer, ... New England Journal of Medicine 377 (5), 454-464, 2017 | 2174 | 2017 |
| Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia RF Schlenk, K Döhner, J Krauter, S Fröhling, A Corbacioglu, L Bullinger, ... New England Journal of Medicine 358 (18), 1909-1918, 2008 | 2084 | 2008 |
| Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions V Goede, K Fischer, R Busch, A Engelke, B Eichhorst, CM Wendtner, ... New England Journal of Medicine 370 (12), 1101-1110, 2014 | 1921 | 2014 |
| Azacitidine and venetoclax in previously untreated acute myeloid leukemia CD DiNardo, BA Jonas, V Pullarkat, MJ Thirman, JS Garcia, AH Wei, ... New England Journal of Medicine 383 (7), 617-629, 2020 | 1866 | 2020 |
| Acute myeloid leukaemia E Estey, H Döhner The Lancet 368 (9550), 1894-1907, 2006 | 1801 | 2006 |
| Retinoic acid and arsenic trioxide for acute promyelocytic leukemia F Lo-Coco, G Avvisati, M Vignetti, C Thiede, SM Orlando, S Iacobelli, ... New England Journal of Medicine 369 (2), 111-121, 2013 | 1673* | 2013 |
| iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL M Hallek, BD Cheson, D Catovsky, F Caligaris-Cappio, G Dighiero, ... Blood, The Journal of the American Society of Hematology 131 (25), 2745-2760, 2018 | 1638 | 2018 |
| Matrix‐based comparative genomic hybridization: biochips to screen for genomic imbalances S Solinas‐Toldo, S Lampel, S Stilgenbauer, J Nickolenko, A Benner, ... Genes, chromosomes and cancer 20 (4), 399-407, 1997 | 1431 | 1997 |
| International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with> 30% blasts H Dombret, JF Seymour, A Butrym, A Wierzbowska, D Selleslag, JH Jang, ... Blood, The Journal of the American Society of Hematology 126 (3), 291-299, 2015 | 1318 | 2015 |
| Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia L Bullinger, K Döhner, E Bair, S Fröhling, RF Schlenk, R Tibshirani, ... New England Journal of Medicine 350 (16), 1605-1616, 2004 | 1246 | 2004 |
| International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data DA Arber, A Orazi, RP Hasserjian, MJ Borowitz, KR Calvo, HM Kvasnicka, ... Blood, The Journal of the American Society of Hematology 140 (11), 1200-1228, 2022 | 1224 | 2022 |
| Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN H Döhner, AH Wei, FR Appelbaum, C Craddock, CD DiNardo, H Dombret, ... Blood, The Journal of the American Society of Hematology 140 (12), 1345-1377, 2022 | 1203 | 2022 |
